APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Albumin Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Albumin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchHuman Albumin Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Albumin Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Human Albumin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Albumin Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Albumin Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Albumin Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Albumin Injection include Takeda, Nanyue Biopharmaceuticals, Grifols, Hualan Bio, Baxter, SK Plasma, Octapharma, Kedrion Biopharma, Inc. and Instituto Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Albumin Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Albumin Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Albumin Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Albumin Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Albumin Injection Segment by Company

Takeda

Nanyue Biopharmaceuticals

Grifols

Hualan Bio

Baxter

SK Plasma

Octapharma

Kedrion Biopharma, Inc.

Instituto Grifols

Green Cross

GE HealthCare

CSL Behring

Biotest (UK) Ltd

Bio Products Laboratory

Human Albumin Injection Segment by Type

Blood Extraction

Recombine

Human Albumin Injection Segment by Application

Hospital

Clinic

Human Albumin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Albumin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Albumin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Albumin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Albumin Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Albumin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Albumin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Albumin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Albumin Injection Industry Trends Table 2. Human Albumin Injection Industry Drivers Table 3. Human Albumin Injection Industry Opportunities and Challenges Table 4. Human Albumin Injection Industry Restraints Table 5. Global Human Albumin Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Albumin Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Albumin Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Human Albumin Injection Sales Market Share by Manufacturers Table 9. Global Human Albumin Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Human Albumin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Albumin Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Albumin Injection Manufacturers, Product Type & Application Table 13. Global Human Albumin Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Albumin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Blood Extraction Table 17. Major Manufacturers of Recombine Table 18. Global Human Albumin Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Human Albumin Injection Sales by Type (2021-2026) & (k units) Table 20. Global Human Albumin Injection Sales by Type (2027-2032) & (k units) Table 21. Global Human Albumin Injection Sales Market Share by Type (2021-2026) Table 22. Global Human Albumin Injection Sales Market Share by Type (2027-2032) Table 23. Global Human Albumin Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Human Albumin Injection Revenue by Type (2021-2026) & (k units) Table 25. Global Human Albumin Injection Revenue by Type (2027-2032) & (k units) Table 26. Global Human Albumin Injection Revenue Market Share by Type (2021-2026) Table 27. Global Human Albumin Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Human Albumin Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Human Albumin Injection Sales by Application (2021-2026) & (k units) Table 32. Global Human Albumin Injection Sales by Application (2027-2032) & (k units) Table 33. Global Human Albumin Injection Sales Market Share by Application (2021-2026) Table 34. Global Human Albumin Injection Sales Market Share by Application (2027-2032) Table 35. Global Human Albumin Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Human Albumin Injection Revenue by Application (2021-2026) & (k units) Table 37. Global Human Albumin Injection Revenue by Application (2027-2032) & (k units) Table 38. Global Human Albumin Injection Revenue Market Share by Application (2021-2026) Table 39. Global Human Albumin Injection Revenue Market Share by Application (2027-2032) Table 40. Global Human Albumin Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Human Albumin Injection Sales by Region (2021-2026) & (k units) Table 42. Global Human Albumin Injection Sales Market Share by Region (2021-2026) Table 43. Global Human Albumin Injection Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Human Albumin Injection Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Human Albumin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 47. North America Human Albumin Injection Sales by Country (2027-2032) & (k units) Table 48. Europe Human Albumin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 50. Europe Human Albumin Injection Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Human Albumin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Human Albumin Injection Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Human Albumin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Human Albumin Injection Sales by Country (2027-2032) & (k units) Table 57. Global Human Albumin Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Human Albumin Injection Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Human Albumin Injection Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Human Albumin Injection Revenue Market Share by Region (2021-2026) Table 61. Global Human Albumin Injection Revenue Market Share by Region (2027-2032) Table 62. Takeda Company Information Table 63. Takeda Business Overview Table 64. Takeda Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Takeda Human Albumin Injection Product Portfolio Table 66. Takeda Recent Development Table 67. Nanyue Biopharmaceuticals Company Information Table 68. Nanyue Biopharmaceuticals Business Overview Table 69. Nanyue Biopharmaceuticals Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolio Table 71. Nanyue Biopharmaceuticals Recent Development Table 72. Grifols Company Information Table 73. Grifols Business Overview Table 74. Grifols Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Grifols Human Albumin Injection Product Portfolio Table 76. Grifols Recent Development Table 77. Hualan Bio Company Information Table 78. Hualan Bio Business Overview Table 79. Hualan Bio Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Hualan Bio Human Albumin Injection Product Portfolio Table 81. Hualan Bio Recent Development Table 82. Baxter Company Information Table 83. Baxter Business Overview Table 84. Baxter Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Baxter Human Albumin Injection Product Portfolio Table 86. Baxter Recent Development Table 87. SK Plasma Company Information Table 88. SK Plasma Business Overview Table 89. SK Plasma Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. SK Plasma Human Albumin Injection Product Portfolio Table 91. SK Plasma Recent Development Table 92. Octapharma Company Information Table 93. Octapharma Business Overview Table 94. Octapharma Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Octapharma Human Albumin Injection Product Portfolio Table 96. Octapharma Recent Development Table 97. Kedrion Biopharma, Inc. Company Information Table 98. Kedrion Biopharma, Inc. Business Overview Table 99. Kedrion Biopharma, Inc. Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolio Table 101. Kedrion Biopharma, Inc. Recent Development Table 102. Instituto Grifols Company Information Table 103. Instituto Grifols Business Overview Table 104. Instituto Grifols Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Instituto Grifols Human Albumin Injection Product Portfolio Table 106. Instituto Grifols Recent Development Table 107. Green Cross Company Information Table 108. Green Cross Business Overview Table 109. Green Cross Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Green Cross Human Albumin Injection Product Portfolio Table 111. Green Cross Recent Development Table 112. GE HealthCare Company Information Table 113. GE HealthCare Business Overview Table 114. GE HealthCare Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. GE HealthCare Human Albumin Injection Product Portfolio Table 116. GE HealthCare Recent Development Table 117. CSL Behring Company Information Table 118. CSL Behring Business Overview Table 119. CSL Behring Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. CSL Behring Human Albumin Injection Product Portfolio Table 121. CSL Behring Recent Development Table 122. Biotest (UK) Ltd Company Information Table 123. Biotest (UK) Ltd Business Overview Table 124. Biotest (UK) Ltd Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Biotest (UK) Ltd Human Albumin Injection Product Portfolio Table 126. Biotest (UK) Ltd Recent Development Table 127. Bio Products Laboratory Company Information Table 128. Bio Products Laboratory Business Overview Table 129. Bio Products Laboratory Human Albumin Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Bio Products Laboratory Human Albumin Injection Product Portfolio Table 131. Bio Products Laboratory Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Human Albumin Injection Distributors List Table 135. Human Albumin Injection Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Human Albumin Injection Product Image Figure 2. Global Human Albumin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Albumin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Albumin Injection Sales (2021-2032) & (k units) Figure 5. Global Human Albumin Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Albumin Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Blood Extraction Image Figure 9. Recombine Image Figure 10. Global Human Albumin Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Human Albumin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Human Albumin Injection Sales Market Share by Type (2021-2032) Figure 13. Global Human Albumin Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Human Albumin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Human Albumin Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Human Albumin Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Human Albumin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Human Albumin Injection Sales Market Share by Application (2021-2032) Figure 21. Global Human Albumin Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Human Albumin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Human Albumin Injection Revenue Market Share by Application (2021-2032) Figure 24. North America Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Human Albumin Injection Sales Market Share by Country (2021-2032) Figure 26. U.S. Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Human Albumin Injection Sales Market Share by Country (2021-2032) Figure 31. Germany Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Human Albumin Injection Sales Market Share by Country (2021-2032) Figure 38. China Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Human Albumin Injection Sales Market Share by Country (2021-2032) Figure 46. Brazil Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Human Albumin Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Human Albumin Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Human Albumin Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Human Albumin Injection Revenue (2021-2032) & (US$ Million) Figure 57. North America Human Albumin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Human Albumin Injection Revenue (2021-2032) & (US$ Million) Figure 59. Europe Human Albumin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Human Albumin Injection Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Human Albumin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Human Albumin Injection Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Human Albumin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Human Albumin Injection Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Human Albumin Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Extraction
  • Recombine
Applications
  • Hospital
  • Clinic
Companies covered
  • Takeda
  • Nanyue Biopharmaceuticals
  • Grifols
  • Hualan Bio
  • Baxter
  • SK Plasma
  • Octapharma
  • Kedrion Biopharma, Inc.
  • Instituto Grifols
  • Green Cross
  • GE HealthCare
  • CSL Behring
  • Biotest (UK) Ltd
  • Bio Products Laboratory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Albumin Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Albumin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Albumin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Albumin Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Albumin Injection Market Dynamics
  1. 2.1 Human Albumin Injection Industry Trends
  2. 2.2 Human Albumin Injection Industry Drivers
  3. 2.3 Human Albumin Injection Industry Opportunities and Challenges
  4. 2.4 Human Albumin Injection Industry Restraints
3 Human Albumin Injection Market by Manufacturers
  1. 3.1 Global Human Albumin Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Albumin Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Albumin Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Albumin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Albumin Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Albumin Injection Manufacturers, Product Type & Application
  7. 3.7 Global Human Albumin Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Albumin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Albumin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Albumin Injection Tier 1, Tier 2, and Tier 3
4 Human Albumin Injection Market by Type
  1. 4.1 Human Albumin Injection Type Introduction
  2. 4.1.1 Blood Extraction
  3. 4.1.2 Recombine
  4. 4.2 Global Human Albumin Injection Sales by Type
  5. 4.2.1 Global Human Albumin Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Human Albumin Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Human Albumin Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Human Albumin Injection Revenue by Type
  9. 4.3.1 Global Human Albumin Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Human Albumin Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Human Albumin Injection Revenue Market Share by Type (2021-2032)
5 Human Albumin Injection Market by Application
  1. 5.1 Human Albumin Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Human Albumin Injection Sales by Application
  5. 5.2.1 Global Human Albumin Injection Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Human Albumin Injection Sales by Application (2021-2032)
  7. 5.2.3 Global Human Albumin Injection Sales Market Share by Application (2021-2032)
  8. 5.3 Global Human Albumin Injection Revenue by Application
  9. 5.3.1 Global Human Albumin Injection Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Human Albumin Injection Revenue by Application (2021-2032)
  11. 5.3.3 Global Human Albumin Injection Revenue Market Share by Application (2021-2032)
6 Global Human Albumin Injection Sales by Region
  1. 6.1 Global Human Albumin Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Albumin Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Human Albumin Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Human Albumin Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Albumin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Albumin Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Albumin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Albumin Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Albumin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Albumin Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Albumin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Albumin Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Albumin Injection Revenue by Region
  1. 7.1 Global Human Albumin Injection Revenue by Region
  2. 7.1.1 Global Human Albumin Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Albumin Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Albumin Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Albumin Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Albumin Injection Revenue (2021-2032)
  8. 7.2.2 North America Human Albumin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Albumin Injection Revenue (2021-2032)
  11. 7.3.2 Europe Human Albumin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Albumin Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Albumin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Albumin Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Albumin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Human Albumin Injection Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Nanyue Biopharmaceuticals
  8. 8.2.1 Nanyue Biopharmaceuticals Company Information
  9. 8.2.2 Nanyue Biopharmaceuticals Business Overview
  10. 8.2.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolio
  12. 8.2.5 Nanyue Biopharmaceuticals Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Human Albumin Injection Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Hualan Bio
  20. 8.4.1 Hualan Bio Company Information
  21. 8.4.2 Hualan Bio Business Overview
  22. 8.4.3 Hualan Bio Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hualan Bio Human Albumin Injection Product Portfolio
  24. 8.4.5 Hualan Bio Recent Developments
  25. 8.5 Baxter
  26. 8.5.1 Baxter Company Information
  27. 8.5.2 Baxter Business Overview
  28. 8.5.3 Baxter Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Baxter Human Albumin Injection Product Portfolio
  30. 8.5.5 Baxter Recent Developments
  31. 8.6 SK Plasma
  32. 8.6.1 SK Plasma Company Information
  33. 8.6.2 SK Plasma Business Overview
  34. 8.6.3 SK Plasma Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SK Plasma Human Albumin Injection Product Portfolio
  36. 8.6.5 SK Plasma Recent Developments
  37. 8.7 Octapharma
  38. 8.7.1 Octapharma Company Information
  39. 8.7.2 Octapharma Business Overview
  40. 8.7.3 Octapharma Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Octapharma Human Albumin Injection Product Portfolio
  42. 8.7.5 Octapharma Recent Developments
  43. 8.8 Kedrion Biopharma, Inc.
  44. 8.8.1 Kedrion Biopharma, Inc. Company Information
  45. 8.8.2 Kedrion Biopharma, Inc. Business Overview
  46. 8.8.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolio
  48. 8.8.5 Kedrion Biopharma, Inc. Recent Developments
  49. 8.9 Instituto Grifols
  50. 8.9.1 Instituto Grifols Company Information
  51. 8.9.2 Instituto Grifols Business Overview
  52. 8.9.3 Instituto Grifols Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Instituto Grifols Human Albumin Injection Product Portfolio
  54. 8.9.5 Instituto Grifols Recent Developments
  55. 8.10 Green Cross
  56. 8.10.1 Green Cross Company Information
  57. 8.10.2 Green Cross Business Overview
  58. 8.10.3 Green Cross Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Green Cross Human Albumin Injection Product Portfolio
  60. 8.10.5 Green Cross Recent Developments
  61. 8.11 GE HealthCare
  62. 8.11.1 GE HealthCare Company Information
  63. 8.11.2 GE HealthCare Business Overview
  64. 8.11.3 GE HealthCare Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GE HealthCare Human Albumin Injection Product Portfolio
  66. 8.11.5 GE HealthCare Recent Developments
  67. 8.12 CSL Behring
  68. 8.12.1 CSL Behring Company Information
  69. 8.12.2 CSL Behring Business Overview
  70. 8.12.3 CSL Behring Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CSL Behring Human Albumin Injection Product Portfolio
  72. 8.12.5 CSL Behring Recent Developments
  73. 8.13 Biotest (UK) Ltd
  74. 8.13.1 Biotest (UK) Ltd Company Information
  75. 8.13.2 Biotest (UK) Ltd Business Overview
  76. 8.13.3 Biotest (UK) Ltd Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biotest (UK) Ltd Human Albumin Injection Product Portfolio
  78. 8.13.5 Biotest (UK) Ltd Recent Developments
  79. 8.14 Bio Products Laboratory
  80. 8.14.1 Bio Products Laboratory Company Information
  81. 8.14.2 Bio Products Laboratory Business Overview
  82. 8.14.3 Bio Products Laboratory Human Albumin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio Products Laboratory Human Albumin Injection Product Portfolio
  84. 8.14.5 Bio Products Laboratory Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Albumin Injection Value Chain Analysis
  2. 9.1.1 Human Albumin Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Albumin Injection Production Mode & Process
  6. 9.2 Human Albumin Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Albumin Injection Distributors
  9. 9.2.3 Human Albumin Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst